Nifty ended at 23,140.50 after an eighth consecutive weekly decline, with technical indicators remaining bearish. Analysts identify 23,300 ...

Jagsonpal Pharmaceuticals has signed a business transfer agreement to acquire the wellness portfolio of Group Pharmaceuticals. The acquisit...

A 40-year-old investor based in Pune is on a mission to retire by age 50 while providing for her two children’s education. With savings of ...

Tata Mutual Fund has launched the Titanium Active Asset Allocator Long-Short Fund, a multi-asset strategy under its SIF framework. The mark...

Abakkus Mutual Fund, led by Sunil Singhania, has received SEBI approval to launch its Specialised Investment Fund (SIF) platform under the ...

HDFC Pharma and Healthcare Fund recorded an impressive 25% return in the last year, surpassing its category average across various time fra...

Aragen Life Sciences is increasing investments in complex drug modalities and manufacturing. The company plans to add significant small-mol...

JioBlackRock CIO Rishi Kohli says largecap valuations have de-rated, while Indian banks have underperformed global peers, creating potentia...

Swedish buyout firm EQT plans to invest $50 billion in India over the next four years, roughly twice the $26 billion it has invested since ...

Quant Mid Cap Fund exited ICICI Bank, Ambuja Cements and L&T Technology Services in August, while adding six stocks including IDBI Bank, Co...

In 2023, while small and mid-cap stocks experienced notable increases, a trend among professional investors is emerging towards largecap co...

Trust Smallcap Fund has emerged as the best performing fund in its category over the past year, delivering a 34% return as investors reasse...

Invesco India Midcap Fund has impressively delivered a 426% return over a decade, showcasing an investment strategy that values robust earn...

The second fund has so far incubated two companies: cancer-care platform Everhope Oncology, built in partnership with Narayana Health, and ...

In the past six months, smallcap mutual funds have delivered excellent returns, prompting investors to reassess their future investment pla...

Sun Pharmaceutical Industries will offer its drugs at prices matching other developed nations. This agreement aims to make healthcare affor...

Sun Pharma ranks second in US dermatology by prescriptions, with key brands including Ilumya for plaque psoriasis and Winlevi for acne. Rec...